Table 2.
Within Group Changes in BMI, Weight, and CVD Risk Factors
| Unadjusted Model 1b N range = 129–151 |
Multivariate Model 2c N range = 127–145 |
|||||||
|---|---|---|---|---|---|---|---|---|
| Within Group Change (SHHC Intervention) | Within Group Change (CON) | Within Group Change (SHHC Intervention) | Within Group Change (CON) | |||||
| Mean Change Baseline to Outcome (95% CI) | p- value | Mean Change Baseline to Outcome (95% CI) | p- value | Mean Change Baseline to Outcome (95% CI) | p-value | Mean Change Baseline to Outcome (95% CI) | p- value | |
| BMIa | −0.80 (−1.18, − 0.43) | <0.001 | −0.10 (−0.49, 0.29) | 0.60 | −0.85 (−1.32, − 0.39) | 0.001 | −0.14 (−0.62, 0.33) | 0.53 |
| Weight, kg | −2.09 (−3.10, −1.08) | <0.001 | −0.23 (−1.28, 0.83) | 0.65 | −2.24 (−3.49, − 0.99) | 0.002 | −0.38 (−1.65, 0.88) | 0.53 |
| CRP | −1.31 (−2.06, − 0.55) | <0.001 | −0.02 (−0.84, 0.80) | 0.96 | −1.13 (−1.89, − 0.37) | 0.004 | 0.03 (−0.75, 0.80) | 0.95 |
| Simple 7 | 0.93 (0.53, 1.33) | <0.001 | 0.32 (−0.11, 0.76) | 0.14 | 0.88 (0.48, 1.28) | <.0.001 | 0.21 (0.21, 0.63) | 0.32 |
| ASCVD Risk | −0.86 (−1.43, − 0.29) | 0.004 | −0.32 (−0.94, 0.29) | 0.30 | −0.96 (−1.49, − 0.43) | <0.001 | −0.47 (−1.01, 0.065) | 0.09 |
| Waist to hip ratio | −0.01 (−0.02, 0.01) | 0.36 | −0.003 (−0.02, 0.01) | 0.64 | −0.01 (−0.02, 0.01) | 0.24 | −0.002 (−0.02, 0.01) | 0.80 |
| Body fat, % | −1.56 (−2.01, − 1.10) | <0.001 | −1.71 (−2.21, − 1.20) | <0.001 | −1.65 (−2.20, − 1.11) | <0.001 | −1.87 (−2.44, − 1.30) | <0.001 |
| Resting heart rate | −2.76 (−4.60, − 0.92) | 0.004 | −1.17 (−3.18, 0.83) | 0.25 | −1.88 (−3.85, 0.08) | 0.06 | −1.15 (−3.16, 0.86) | 0.26 |
| Diastolic blood pressure, mmHg | −6.46 (−9.60, − 3.32) | <0.001 | −4.53 (−7.73, − 1.32) | 0.009 | −6.45 (−9.63, − 3.28) | <0.001 | −3.89 (−7.09, − 0.68) | 0.02 |
| Systolic blood pressure, mmHg | −6.57 (−10.51, − 2.64) | 0.003 | −4.14 (−8.21, − 0.07) | 0.05 | −5.91 (−10.35, − 1.46) | 0.01 | −3.85 (−8.32, 0.63) | 0.09 |
| Waist circumference, cm | −3.39 (−6.10, − 0.68) | 0.02 | −2.10 (−4.84, 0.64) | 0.12 | −3.23 (−5.78, − 0.68) | 0.02 | −1.83 (−4.41, 0.75) | 0.15 |
| Cholesterol (total), mg/dL | 2.68 (−5.43, 10.79) | 0.49 | −9.41 (−17.72, − 1.10) | 0.03 | 3.92 (−4.22, 12.06) | 0.32 | −7.85 (−16.05, 0.35) | 0.06 |
| HDL cholesterol, mg/dL | 0.93 (−1.75, 3.61) | 0.47 | 0.55 (−2.21, 3.32) | 0.68 | 1.81 (−0.88, 4.50) | 0.17 | 0.54 (−2.18, 3.26) | 0.68 |
| LDL cholesterol, mg/dL | 0.08 (−5.47, 5.63) | 0.98 | −8.08 (−13.83, − 2.32) | 0.009 | 0.99 (−5.02, 7.01) | 0.73 | −6.55 (−12.60, − 0.51) | 0.04 |
| Triglycerides, mg/dL | −5.28 (−20.49, 9.94) | 0.46 | −9.45 (−25.14, 6.24) | 0.22 | −3.39 (−16.97, 10.18) | 0.60 | −6.79 (−20.46, 6.89) | 0.31 |
| Fasting glucose, mg/dL | 2.66 (−1.57, 6.89) | 0.22 | 5.61 (1.00, 10.22) | 0.02 | 3.42 (−1.08, 7.92) | 0.14 | 5.06 (0.46, 9.67) | 0.03 |
| Hemoglobin A1c | −0.28 (−0.40, − 0.16) | <0.001 | −0.28 (−0.41, − 0.16) | <0.001 | −0.26 (−0.38, − 0.14) | <0.001 | −0.28 (−0.40, − 0.16) | <0.001 |
Boldface indicates statistical significance (p≤0.05)
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CON, Strong Hearts, Healthy Women-Control; CRP, c-reactive protein; HDL, high density lipoprotein; LDL, low density lipoprotein; SHHC, Strong Hearts, Healthy Communities.
a
Calculated as weight in kilograms divided by height in meters squared.
b
Adjusted for Site
c
Adjusted for Site, Education, Age, Marital Status, and Baseline Value of the Outcome